Related Experiment Videos

Serum levels of digoxin in sudden cardiac deaths

Insights

Postmortem digoxin levels in cardiac arrest patients revealed varied concentrations. Many patients had low or undetectable digoxin, highlighting potential issues with therapeutic drug monitoring and sampling techniques in forensic pathology.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Forensic Pathology

Background:

  • Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
  • Accurate digoxin levels are crucial for therapeutic drug monitoring and postmortem investigations.
  • Sudden cardiac death necessitates understanding the role of medications like digoxin.

Purpose of the Study:

  • To determine digoxin concentrations in postmortem serum samples of patients who died from cardiac disease.
  • To assess the correlation between digoxin levels and cause of death in cardiac patients.
  • To emphasize the importance of accurate digoxin level determination and sampling techniques in forensic analysis.

Main Methods:

  • Serum samples were collected from 100 postmortem cases of sudden cardiac death.
  • Digoxin concentrations were measured using established laboratory assays.
  • Data analysis focused on categorizing digoxin levels relative to the therapeutic range (1.2-2.5 nmol/l).

Main Results:

  • 34% of patients had undetectable digoxin levels (<0.5 nmol/l).
  • 21% had levels within the therapeutic range (1.2-2.5 nmol/l).
  • 10% showed probable digoxin overdosage, and 15% had markedly elevated levels.

Conclusions:

  • A significant proportion of patients had subtherapeutic or undetectable digoxin levels, suggesting potential undertreatment or drug elimination.
  • Elevated digoxin levels in some cases indicate potential toxicity as a contributing factor to cardiac death.
  • Accurate postmortem digoxin level determination and proper sample collection are vital for accurate forensic and clinical interpretation.

Related Concept Videos